LSW EVS WIN venture Ora Biomedical has received an NIH SBIR Phase 1 award from the National Institute on Aging to support RadBot, a program focused on identifying natural compounds that may help protect cells from UV-related damage. The one-year project will screen compounds in C. elegans before advancing top candidates for testing in human cells.
Ora Biomedical Awarded NIH SBIR Grant from the National Institute on Aging for RadBot
Share: